Literature DB >> 10571347

Clinical and immunocytochemical findings in a case of melanoma-associated retinopathy.

M J Potter1, C E Thirkill, O M Dam, A S Lee, A H Milam.   

Abstract

OBJECTIVE: To describe an unusual case of melanoma-associated retinopathy (MAR).
DESIGN: Retrospective, observational case report and experimental study. PARTICIPANTS: A 61-year-old man with a history of cutaneous melanoma, acquired bilateral central scotomas, and night blindness. INTERVENTION: Serial full-field electroretinography (ERG) and Goldmann perimetry were performed. Serum was screened for cancer-associated retinopathy (CAR) antibodies by Western blotting. Sections of human and rat retina were examined by immunofluorescence microscopy to determine whether retinal cells were reactive with this patient's serum. A metastatic workup was performed. MAIN OUTCOME MEASURES: Electroretinography, Goldmann visual field testing, and immunocytochemistry were performed.
RESULTS: The results were as follows: (1) The ERG showed a profound loss of the b-wave amplitude and a "negative" b-wave characteristic of congenital stationary night blindness; (2) a central scotoma and peripheral constriction were identified on Goldmann visual field tests; (3) as in other patients with MAR, bipolar cells in human and rat retinas were immunolabeled with this patient's serum; and (4) a previously unsuspected focus of metastatic melanoma was discovered.
CONCLUSIONS: Recognition of this condition may help to identify an occult focus of metastatic melanoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10571347     DOI: 10.1016/S0161-6420(99)90493-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  7 in total

1.  Melanoma-associated retinopathy: a paraneoplastic autoimmune complication.

Authors:  Ying Lu; Lin Jia; Shirley He; Mary C Hurley; Monique J Leys; Thiran Jayasundera; John R Heckenlively
Journal:  Arch Ophthalmol       Date:  2009-12

Review 2.  Retinal Diseases that Can Masquerade as Neurological Causes of Vision Loss.

Authors:  Tanyatuth Padungkiatsagul; Loh-Shan Leung; Heather E Moss
Journal:  Curr Neurol Neurosci Rep       Date:  2020-09-15       Impact factor: 5.081

3.  Autoantibodies to transient receptor potential cation channel, subfamily M, member 1 in a Japanese patient with melanoma-associated retinopathy.

Authors:  Yukiko Morita; Kazuhiro Kimura; Youichiro Fujitsu; Atsushi Enomoto; Shinji Ueno; Mineo Kondo; Koh-Hei Sonoda
Journal:  Jpn J Ophthalmol       Date:  2014-01-29       Impact factor: 2.447

4.  A negative electroretinogram (ERG) in a case of probable multiple system atrophy (MSA).

Authors:  Claire S Barnes; Jiong Yan; George R Wilmot
Journal:  Doc Ophthalmol       Date:  2008-11-21       Impact factor: 2.379

5.  Paraneoplastic Retinopathy/Optic Neuropathy.

Authors:  Denise M Damek
Journal:  Curr Treat Options Neurol       Date:  2005-01       Impact factor: 3.972

6.  Optical coherence tomography findings in paraneoplastic pseudovitelliform lesions in melanoma-associated retinopathy.

Authors:  Michael Javaheri; Rahul N Khurana; Rizwan A Bhatti; Jennifer I Lim
Journal:  Clin Ophthalmol       Date:  2008-06

7.  Autoimmune retinopathy with associated anti-retinal antibodies as a potential immune-related adverse event associated with immunotherapy in patients with advanced cutaneous melanoma: case series and systematic review.

Authors:  Jacob S Heng; Jenna M Kim; D Kyle Jones; Kathleen M Stoessel; Sarah A Weiss; Mario Sznol; Harriet M Kluger; Scott D Walter; Niki A Silverstein; Renelle Pointdujour-Lim
Journal:  BMJ Open Ophthalmol       Date:  2022-01-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.